Stock Updates

A look at a High Market Cap Stock: Quest Diagnostics Inc., DGX

Quest Diagnostics Inc., DGX is in the exchange NYSE and its industry is Medical Laboratories & Research in the sector of Healthcare. Based in USA, Quest Diagnostics Inc., DGX  has a market cap of 11524.31. Since its IPO date on the 12/26/1996, Quest Diagnostics Inc., DGX performance year to date is 18.70%. Today Quest Diagnostics Inc., DGX has gained -0.22%, with a current price of 83.1.

Ownership of the company is 0.20% for insider ownership while institutional ownership is 96.80%. The management of the company have seen the company have a payout ratio of 27.10%. Return of assets are at 8.20%, with return on investment at 12.30%.

In terms of debt levels and profit levels, Quest Diagnostics Inc., DGX is seeing a long-term debt/equity of 0.85. While Total debt/equity is 0.85. With a profit margin of 11.00%, this is combined with a gross margin of 38.70%, and operating margin of 20.70%. Quest Diagnostics Inc. ability to meet debt levels, with a current ratio of 1.4, while the quick ratio is 1.3.

For the last year Quest Diagnostics Inc., DGX has seen a EPS growth of 28.60%. A performance for the year of 26.25%. The 52-week high is -4.32%, and the 52-week low is 41.45%. The average volume for Quest Diagnostics Inc., DGX is 668100.

With a target price of 82.89, can Quest Diagnostics Inc., DGX reach this target? Looking at the value indicators of Quest Diagnostics Inc., DGX. Quest Diagnostics Inc. has a P/E of 14.54 and a forward P/E of 15.25. Perhaps the more useful indicator than P/E, is PEG which has a value of 1.91. Quest Diagnostics Inc. also has a P/S and a P/B of 1.54 and 2.56 respectively. For P/cash, Quest Diagnostics Inc. has a value of 40.72, while it is 32.01 for P/free cash flow.

At the current price of 83.1, Quest Diagnostics Inc. has a dividend yield of 1.93%. We see a return on equity of 17.90%.

Looking more long-term Quest Diagnostics Inc., is projected to get an EPS growth for the next five years of 7.63%. In the short-term an EPS growth of 6.74% in the next year is forecasted. This is after a EPS growth of 28.60% for this year and for the last five years a 4.10% growth has been seen.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment